IntElligo Research Stack™ Technology
Streamlining data collection from patient identification to study close.
IntElligo Research Stack™ technology is the only system designed to work in a real-world healthcare environment, collecting data at the point of care using CDISC global research data standards and automatically preparing it for regulatory compliance and submission.
As part of Elligo’s continued strategy to connect the best healthcare experts with the best research technologies and infrastructure, the system prioritizes data interoperability, promotes study efficiency, and provides all stakeholders with real-time transparency into the patient’s entire journey. This system accelerates and enhances data collection from feasibility through submission by automating administrative tasks, alerting for any quality issues, and streamlining data output — all while maintaining the integrity of the trusted physician and patient relationship.
Accelerated data collection
Enhanced data output
Real-time data updates and analytics
Identify and Recruit Patients
The PatientFinder feature reduces study startup time by using electronic health records to fill studies with patients from Elligo’s Research Ready network. The system uses a patent-pending process to identify patients and progress them through a configurable prescreening process.
Collect Standards-Based Study Data
The DirectSource feature improves data collection and quality by aligning with the healthcare workflow and collecting patient source data. Within this feature, patient source data collection requirements are aligned with CDISC standards, which facilitates data interoperability and ensures consistency across all healthcare partners and studies. As study coordinators and healthcare physicians record patient data, all necessary patient and financial tracking is automated.
Manage and Track Your Study
The StudyWatch feature is an all-inclusive, end-to-end study management dashboard that displays the tools you need to manage the overall study. From planning and preparation to performance and tracking, this feature establishes real-time transparency across the entire research spectrum — including study startup, study conduct, and issue management. A unique set of integrated analysis tools support the audit of key metrics and important performance indicators from your study. Data from real-world healthcare environments allow our dashboards to provide stakeholders with key insights to support study decisions.
Expedite Your Study Financials
The DirectPay feature automates financial tasks and reporting, providing transparency and improving compliance for clinical research. The system ties all financial transactions to source data and study milestones, allowing for real-time physician payment and patient stipend distribution. This feature provides transparency into all financial information relating to the study.
Interoperability
IntElligo Research Stack™ clinical technology prioritizes data interoperability by collecting trial information in CDISC CDASH standards, which facilitates integration with EDC systems and data warehouses using ODM interchange format.
Additionally, the system integrates with other key vendors including patient stipend and external recruitment systems. Automatically validating, monitoring and generating generic descriptive statistics of patient data provides study sponsors real-time transparency into the patient journey and allows them to make well-informed, proactive decisions.
Physicians
- Easier oversight
- Remote reviews
- Reduced tracking
- Easier access to data
- Support for healthcare workflow
- Faster payments
Sponsors
- Improved visibility
- Remote monitoring
- Transparency to real-time patient journey
- Interoperability
- Patient centricity
- PI satisfaction
Elligo
- Quality oversight
- Efficient study conduct
- Real-time transparency
- Paperless study conduct
- Automated study administration processes
Notes From Our Network
“Endometriosis is routinely a hard disease to treat. Incorporating research into our practice gives us the ability to serve patients who are not seeing the results they want with existing medications or current treatment options.”